“A vaccine protecting against two types of viruses that cause cervical cancer has demonstrated unusual staying power, new research shows.
“In a follow-up study to a randomized clinical trial, researchers found antibody levels in the study subjects remained steadfast for up to four and a half years. Researchers say the results confirm the success and safety of the vaccine Cervarix, which is designed to guard against two cancer-causing human papillomaviruses, HPV 16 and 18.
“‘This is the most significant advance in cancer prevention in the last 50 years,’ said lead author Diane Harper, director of Gynaecologic Cancer Prevention Research at Dartmouth Medical School. ‘We now have a vaccine that’s 100 percent effective,’ she added.
“She also emphasized the vaccine does not prevent cancer — it prevents the virus that causes cervical cancer, the second most common malignant disease in women worldwide.
read more | digg story